• Y-mAbs Therapeutics' (YMAB) "Outperform" Rating Reaffirmed at Wedbush

    Источник: Buzz FX / 04 мар 2025 18:51:14   America/New_York


    Y-mAbs Therapeutics' (YMAB) "Outperform" Rating Reaffirmed at Wedbush Written by MarketBeat March 4, 2025 Share Link copied to clipboard. Y-mAbs Therapeutics ( NASDAQ:YMAB - Get Free Report ) 's stock had its "outperform" rating reaffirmed
    Read more...
Опубликовать